What is the appropriate first‑line antibiotic regimen for a 61 kg adult who is allergic to ceftriaxone and penicillin?

Respiratory Fluoroquinolone as First-Line Therapy

For a 61 kg adult allergic to both ceftriaxone and penicillin, a respiratory fluoroquinolone (levofloxacin 750 mg daily or moxifloxacin 400 mg daily) is the appropriate first-line antibiotic regimen for most common bacterial infections requiring empiric therapy. 1

Clinical Context and Rationale

Your dual allergy to penicillin and ceftriaxone eliminates the most commonly used first-line antibiotics across multiple infection types. The cross-reactivity between penicillins and cephalosporins (including ceftriaxone) ranges from 1-10%, but given your documented allergy to both classes, all beta-lactams should be avoided 2.

Specific Recommendations by Infection Type

Community-Acquired Pneumonia (Outpatient)

• Respiratory fluoroquinolone (levofloxacin 750 mg daily or moxifloxacin 400 mg daily) 1
• This is the strong recommendation with level I evidence for penicillin-allergic patients

Community-Acquired Pneumonia (Hospitalized, Non-ICU)

• Respiratory fluoroquinolone monotherapy 1
• The guideline explicitly states: "A respiratory fluoroquinolone should be used for penicillin-allergic patients"

Community-Acquired Pneumonia (ICU Setting)

• Respiratory fluoroquinolone PLUS aztreonam 1
• Aztreonam is specifically recommended as the beta-lactam substitute in penicillin-allergic patients because it has minimal cross-reactivity with other beta-lactams

Acute Bacterial Rhinosinusitis

• First choice: Levofloxacin or moxifloxacin 3
• Alternative: Doxycycline (100 mg twice daily) 3
• The 2015 sinusitis guideline explicitly recommends fluoroquinolones for penicillin-allergic patients

Bacterial Meningitis

• Respiratory fluoroquinolone (moxifloxacin 400 mg daily) PLUS aztreonam 4, 5, 6
• This combination provides coverage for both typical and atypical pathogens while avoiding beta-lactam exposure
• For confirmed pneumococcal meningitis in penicillin-allergic patients, chloramphenicol 25 mg/kg every 6 hours is an alternative 4

Important Caveats and Pitfalls

Cross-Reactivity Considerations

While some recent research suggests cefazolin may be safe in certain penicillin-allergic patients 7, 8, 9, your documented allergy to ceftriaxone specifically makes this approach inappropriate. The FDA label for ceftriaxone explicitly contraindicates its use in patients with known hypersensitivity to cephalosporins and warns about cross-reactivity risk with penicillin-allergic patients 2.

When Fluoroquinolones Are Not Ideal

• Avoid as first-line if you have no comorbidities and are being treated outpatient for simple infections, as this promotes resistance 1
• Clindamycin 600-900 mg every 8 hours can be used for skin/soft tissue infections 10
• Doxycycline 100 mg twice daily is acceptable for sinusitis and some respiratory infections 3, 1

Pseudomonas Coverage (if needed)

If Pseudomonas is a concern (chronic lung disease, recent hospitalization, frequent antibiotics):

• Ciprofloxacin 400 mg IV every 12 hours OR levofloxacin 750 mg daily
• PLUS aztreonam (2 g every 8 hours) 1
• PLUS an aminoglycoside (gentamicin or tobramycin) for severe infections

MRSA Coverage (if needed)

Add vancomycin (15-20 mg/kg every 8-12 hours, targeting trough 15-20 mcg/mL) or linezolid (600 mg every 12 hours) 1, 10

Practical Algorithm

1. Determine infection severity and location
2. For most common infections: Start respiratory fluoroquinolone monotherapy
3. For severe infections or ICU patients: Add aztreonam to fluoroquinolone
4. If Pseudomonas risk: Use ciprofloxacin/levofloxacin + aztreonam + aminoglycoside
5. If MRSA risk: Add vancomycin or linezolid to above regimens
6. For simple skin infections: Consider clindamycin alone

The key principle is that respiratory fluoroquinolones provide the broadest, safest coverage for patients with your allergy profile, with aztreonam serving as the go-to beta-lactam substitute when additional gram-negative coverage is needed.